Published May 19, 2021 | Version 1
Dataset Open

Risk of bias assessments for the Cochrane review 'Vitamin D supplementation for the treatment of COVID-19: a living systematic review'

Authors/Creators

  • 1. Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  • 2. Department of Anaesthesiology and Intensive Care Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany
  • 3. Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
  • 4. Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
  • 5. Department of Intensive Care Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany
  • 6. Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

Description

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Vitamin D supplementation for the treatment of COVID-19: a living systematic review

Notes

The research was part of a project supported by the Federal Ministry of Education and Research in Germany (NaFoUniMedCovid19, funding number: 01KX2021; part of the project "CEOSys"). The contents of this document reflect only the authors' views and the German Ministry is not responsible for any use that may be made of the information it contains.

Files

Files (695.6 kB)

Additional details

Related works

Is supplement to
Journal article: 10.1002/14651858.CD015043 (DOI)